[1]金春林,彭 颖,王海银.深化医疗服务价格改革的内涵与思考[J].卫生经济研究,2022,39(1):7-9,12.
　JIN Chun-lin,PENG Ying,WANG Hai-yin.The Connotation and Thinking of Deepening the Medical Service Price Reform[J].Journal Press of Health Economics Research,2022,39(1):7-9,12.
点击复制

深化医疗服务价格改革的内涵与思考
分享到：

卫生经济研究[ISSN:1004-7778/CN:33-1056/F]

卷:
39
期数:
2022年1期
页码:
7-9,12
栏目:
特稿
出版日期:
2022-01-07

文章信息/Info

Title:
The Connotation and Thinking of Deepening the Medical Service Price Reform
作者:
金春林1; 彭 颖2; 王海银1
1.上海市卫生和健康发展研究中心（上海市医学科学技术情报研究所），上海 200040
2.中国福利会国际和平妇幼保健院（上海交通大学医学院附属国际和平妇幼保健院），上海 200030
Author(s):
JIN Chun-lin;  PENG Ying;  WANG Hai-yin
Shanghai Health Development Research Center (Shanghai Institute of Medical Science and Technology Information), Shanghai 200040, China
关键词:
医疗服务价格改革; 医保支付; 资源配置; 管理模式
Keywords:
medical service price reform;  medical insurance payment;  resource allocation;  management mode
分类号:
R197.322
文献标志码:
A
摘要:
我国医疗服务价格改革对推动公立医院补偿机制转轨、促进医疗技术进步、支持医疗事业发展起到了积极作用，但也面临一些历史局限。新形势下，深化医疗服务价格改革的内涵主要体现在规范项目、总量调控、分类管理、动态调整、监测考核5个方面，要正确处理医疗服务价格改革与药品耗材带量采购、医保支付方式改革的关系，建立以健康为中心的驱动机制，实现医保支付与价格改革的三重境界。
Abstract:
China's medical service price reform has played a positive role in promoting the transformation of public hospitals' compensation mechanism, promoting the advancement of medical technology, and supporting the development of medical industry. However, it also faces some historical limitations. Under the new situation, the connotation of deepening medical service price reform is mainly reflected in the five aspects: standardized medical service charge items, total volume control, classified management, dynamic adjustment, and monitoring and evaluation. It is necessary to correctly handle the relationships between medical service price reform, volume-based procurement, and medical insurance payment reform, and to establish a health-centered driving mechanism, so as to realize the triple function of medical insurance payment and price reform.

参考文献/References:

[1] 王越，吴硕，张斌，等.医疗服务价格调整对医保住院患者费用结构的影响[J].中国医疗保险，2018（9）：49-53.
[2] 刘宝，顾善清.基于13个省份的医疗服务价格项目比较分析[J].中华医院管理杂志，2014，30（1）：31-33.
[3] WANG H,JIN C,JIANG Q.Price adjustment for traditional Chinese medicine procedures:based on a standardized value parity model[J].BioScience Trends,2017,11(5):524-532.
[4] 王海银，金春林.国际医疗服务项目支付优化策略及启示[J]. 卫生经济研究，2019，36（8）：16-19.
[5] 陆忆娟，马爱霞，唐文熙.城市公立医院医药价格综合改革述评[J].中国医院管理，2018，38（4）：8-11，24.
[6] 张璐,王敏.我国医疗服务价格问题成因及改革路径探析[J]. 经济研究导刊，2018（4）：47-49，154.
[7] 金春林，王海银.新形势下医疗服务价格改革的挑战及发展思路[J].中国卫生资源，2021，24（5）：489-491.
[8] 金维加. 安徽：耗材改革不仅仅是“砍价”[J].中国卫生，2019（9）：60-61.
[9] 魏广，万勇，杨朔.安徽省高值医用耗材带量采购的实践与思考[J].中国医疗保险，2020（8）：47-50，54.
[10] 朱琳琳.大型医用设备集中采购取得阶段性成效[N].安徽日报，2021-08-09（002）.

相似文献/References:

[1]胡庆慧,丁金华.基层医疗卫生机构医疗服务价格改革研究[J].卫生经济研究,2017,(09):34.
[2]田文华.上海市医保支付改革方案的设计和模拟分析[J].卫生经济研究,2018,(02):22.
[3]方福祥.基于取消药品加成的医疗服务价格调整实践探索[J].卫生经济研究,2018,(07):27.
[4]陈东升.医疗服务价格动态调整机制研究[J].卫生经济研究,2019,(04):46.
　CHEN Dong-sheng.Research on the Dynamic Adjustment Mechanism of Medical Service Price[J].Journal Press of Health Economics Research,2019,(1):46.
[5]王 岳,郑培永,刘 宝.我国公立医院收入结构变化特征分析[J].卫生经济研究,2020,(03):60.
　WANG Yue,ZHENG Pei-yong,LIU Bao.Analysis on the Characteristics of the Income Structure of Public Hospitals in China[J].Journal Press of Health Economics Research,2020,(1):60.
[6]梁 冰,王前强,陈凤磊,等.国家谈判药品对综合医院医保管理的影响及对策[J].卫生经济研究,2020,(05):42.
　LIANG Bing,WANG Qian-qiang,CHEN Feng-lei,et al.Impact of National Negotiation Drugs on Medical Insurance Management in General Hospitals and Countermeasures[J].Journal Press of Health Economics Research,2020,(1):42.
[7]路娜娜,徐 伟,杜雯雯,等.美国互联网医疗服务的医保支付政策及启示[J].卫生经济研究,2020,(10):37.
　LU Na-na,XU Wei,DU Wen-wen,et al.Medical Insurance Payment Policy and Enlightenment of American Internet Medical Service[J].Journal Press of Health Economics Research,2020,(1):37.
[8]姚奕婷,陈元栋,张远妮,等.广东省公立医院取消药品、医用耗材加成的效果研究[J].卫生经济研究,2020,(12):32.
　YAO YI-ting,CHEN Yuan-dong,ZHANG Yuan-ni,et al.Study on the Effect of Canceling the Addition of Drugs and Medical Consumables in Public Hospitals in Guangdong Province[J].Journal Press of Health Economics Research,2020,(1):32.
[9]于保荣.DRG与DIP的改革实践及发展内涵[J].卫生经济研究,2021,38(1):4.
　YU Bao-rong.Reform Practice and Development Connotation of DRG and DIP[J].Journal Press of Health Economics Research,2021,38(1):4.
[10]王海银,丛鹂萱,谢春艳,等.我国创新药品医保支付改革的进展及思考[J].卫生经济研究,2021,38(1):47.
　WANG Hai-yin,CONG Li-xuan,XIE Chun-yan,et al.Progress and Consideration on the Medical Insurance Payment Reform for Innovative Drugs in China[J].Journal Press of Health Economics Research,2021,38(1):47.

更新日期/Last Update: 2022-01-07